Related Experiment Video
Updated: Jan 28, 2026

Three Dimensional Cultures: A Tool To Study Normal Acinar Architecture vs. Malignant Transformation Of Breast Cells
Published on: April 25, 2014
Germ Cell Tumors with Malignant Somatic Transformation: A Mayo Clinic Experience
Background:
Germ cell tumors (GCTs) with malignant somatic transformation (MST) represent an uncommon variant of what is typically a curable malignancy. There is a paucity of data on time of somatic transformation, response to conventional therapy, and survival outcomes of different somatic subtypes.
Methods:
After obtaining institutional review board (IRB) approval, we searched our institutional database from 1982 to 2017 and identified patients with GCTs with MST. Patient characteristics, pathologic description, treatment, and clinical outcomes were extracted from the medical records.
Results:
We identified 24 cases of GCTs with MST; the MST was adenocarcinoma in 50% and sarcoma in 50%. Median age at diagnosis was 27. Alpha-fetoprotein and beta-human chorionic gonadotropin were undetectable in 44%, both were elevated in 54%. The majority were advanced stage (71% stage III), and International Germ Cell Cancer Collaborative Group (IGCCCG) risk was classified as 'good' in 60%. Median follow-up was 41 months (range 10-346 months). Median progression-free survival was 84 months (95% confidence interval (CI) 56-232), and median overall survival was 219 months (95% CI 165-not reported).
Conclusion:
Patients with GCTs with an MST appear to have poor responses to cisplatin-based chemotherapy, suggesting that somatic component-driven therapies should be considered. Furthermore, resection of residual disease when feasible is an essential component of management.
Insights
Malignant somatic transformation (MST) in germ cell tumors (GCTs) is rare, with poor response to standard chemotherapy. Targeted therapies and surgical resection are crucial for managing these aggressive GCTs.
Area of Science:
- Oncology
- Pathology
- Genitourinary Cancers
Background:
- Germ cell tumors (GCTs) with malignant somatic transformation (MST) are uncommon, with limited data on outcomes.
- Understanding MST subtypes and their impact on treatment response is critical.
Purpose of the Study:
- To analyze the characteristics, treatment, and survival of patients with GCTs and MST.
- To identify optimal management strategies for GCTs with MST.
Main Methods:
- Retrospective review of 24 GCTs with MST cases from 1982-2017.
- Extraction of patient demographics, pathology, treatment, and clinical outcomes.
Main Results:
- MST subtypes were equally adenocarcinoma and sarcoma (50% each).
- Most patients had advanced stage (71% stage III) disease.
- Median progression-free survival was 84 months; median overall survival was 219 months.
Conclusions:
- GCTs with MST show poor response to cisplatin-based chemotherapy.
- Somatic component-driven therapies and surgical resection of residual disease are recommended.
Related Concept Videos
Somatic to iPS Cell Reprogramming
Bacterial Transformation
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
Cancers Originate from Somatic Mutations in a Single Cell
Somatic Spinal Reflexes
One of the most well-known somatic spinal reflexes is the stretch reflex, which is activated by the sudden stretching of a muscle. This reflex involves the activation of specialized sensory receptors called muscle spindles, which are located in the muscle tissue and detect changes in the length and speed of muscle contractions. When a muscle is suddenly...
Transformation
Transformers
The iron core has a substantial relative permeability. Therefore, the magnetic field lines generated due to the current in one winding are almost entirely confined within the core, such that the same magnetic flux permeates each turn of both...

